Federal 7-OH Scheduling: What It Means for Your Orders
Compliance and Transparency Update
Compliance Update: The Federal 7-OH Scheduling Proposal
Our position on the July 2026 federal action affecting 7-OH and related compounds, what it means for your orders, and how customers can participate in the public process.
A note on our commitment
We operate with a commitment to transparency and responsible business practices. In that spirit, we want our customers to hear directly from us about a significant federal development affecting a portion of our catalog, and about the steps we are taking in response.
What has been proposed
On July 1, 2026, the U.S. Drug Enforcement Administration announced its intent to temporarily place concentrated 7-hydroxymitragynine, or 7-OH, into Schedule I of the Controlled Substances Act. The notices were published in the Federal Register on July 6, 2026, following scientific review and a recommendation by the Department of Health and Human Services and the FDA.
The action has two components. The first proposes scheduling 7-OH above a specified threshold. As written, that threshold covers material containing more than 0.050 percent 7-OH by dry weight, or, for synthetic and processed material, more than 0.050 percent by concentration or more than one milligram of 7-OH per article. The one milligram per article standard is low enough to encompass the large majority of concentrated 7-OH products in the market. The second component would schedule three synthetic derivatives of 7-OH, mitragynine pseudoindoxyl (MP), MGM-15, and MGM-16, with no threshold.
Which products are affected
The products affected are those defined by the compounds above. Any product containing concentrated or synthetic 7-OH above the proposed threshold would be covered, as would any product containing MP, MGM-15, or MGM-16. A number of items in our catalog fall into these categories, and we are conducting a full review of affected listings.
Products that are not affected include natural leaf kratom containing only naturally occurring, below threshold 7-OH, and any product whose active alkaloid is mitragynine, which is not part of this action.
Compliance and our position
We intend to comply fully with federal law. If and when a temporary scheduling order takes effect, we plan to discontinue the sale of covered products. Because the timeline remains subject to the federal process, we are not publishing a fixed cutoff date. We will stop selling covered products as soon as federal enforcement takes effect, and we will update this page and notify customers as the situation develops.
We believe in responsible regulation over prohibition. A threshold set too low risks removing products that many adults use responsibly and pushing demand toward an unregulated market. We support a clear, science based threshold, and we encourage our customers to make their own views known through the official public channels described below.
How customers can participate
The federal government has specifically invited public comment on the proposed threshold. Public participation has influenced kratom related decisions before, most notably in 2016, when a similar action was withdrawn after more than one hundred thousand comments. The window is open now, and it closes on July 31, 2026.
| Action | Where to go |
|---|---|
| Submit a public comment | Comment on the HHS Request for Information (docket HHS-OASH-2026-0232) at regulations.gov. Comments are accepted through July 31, 2026. Personal, specific comments carry more weight than form letters. |
| Contact your representatives | Find and call your U.S. Representative and Senators using Common Cause. Ask them to urge HHS and the DEA to adopt a science based, reasonable threshold. |
| Sign the petition | Add your name to the national petition on Change.org, which has gathered tens of thousands of signatures. |
| Learn more and organize | Visit the 7-HOPE Alliance federal action hub for talking points, organizing calls, and step by step guidance on commenting. |
What this means for you
- For now, affected products remain available while we complete our review and while the rule is not yet in effect.
- When an order takes effect, we will discontinue covered products in an orderly way and communicate clearly at each step.
- Your orders and support are unaffected in the meantime, and our customer service team is available for any questions.
Frequently asked questions
Are these products banned today?
No. The action is a proposal with an open comment period. No temporary scheduling order has taken effect.
When will you stop selling covered products?
As soon as federal enforcement takes effect. We are not setting a fixed date because the federal timeline is still in progress.
Which products are covered?
Products containing concentrated or synthetic 7-OH above the proposed threshold, and any product containing MP, MGM-15, or MGM-16. Natural leaf kratom below the threshold and mitragynine are not covered.
What is the most effective way to participate?
Submit a personal comment at regulations.gov under docket HHS-OASH-2026-0232 before July 31, 2026, and contact your elected representatives.
We are grateful for your continued trust. If you have any questions, please reach out to our customer service team.
Sincerely,
The Compliance Team
This update is provided for general information and does not constitute legal advice. Details reflect the federal notices published July 6, 2026 and may change as the rulemaking proceeds.
